Nostrum Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOSTRUM LABS, and what generic and branded alternatives to NOSTRUM LABS drugs are available?
NOSTRUM LABS has fifty-eight approved drugs.
Summary for Nostrum Labs
| US Patents: | 0 |
| Tradenames: | 54 |
| Ingredients: | 50 |
| NDAs: | 58 |
Drugs and US Patents for Nostrum Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Labs | ATENOLOL | atenolol | TABLET;ORAL | 074127-001 | Feb 21, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Nostrum Labs | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 074404-001 | May 14, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Nostrum Labs Inc | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205468-002 | Mar 24, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
